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Abstract
Background: Cervical intraepithelial neoplasia (CIN) can be a precursor to the development of invasive
cervical cancer. There are two ways to approach the treatment of CIN, observation or immediate treatment.
For women with CIN1, most often observation is the best choice. Women diagnosed with CIN2 or CIN3
typically undergo immediate treatment, due to the increased likelihood of progression. LEEP is currently the
procedure of choice, and its association with preterm delivery has been a topic of debate. Many studies have
been done analyzing the LEEP in an attempt to investigate the association, and while this is a promising tool
in the treatment of cervical cancer, more research needs to be done to reach a definitive conclusion.
Methods: A comprehensive search of the medical literature published within the last five years was conducted
using MEDLINE, CINAHL, and EBM Multifile. Search terms used were: cervical intraepithelial neoplasia,
loop electrosurgical excision procedure, and pregnancy complications. Web of Science was used in a
secondary search to locate articles of interest from the references of the included articles. Each article was
filtered based on strict inclusion and exclusion criteria, and then critically appraised. The validity of each
article was assessed using the criteria located in Table I.
Results: A total of seven articles were critically appraised. These articles are addressed in Table II. After the
appraisal, one article was eliminated due to receiving a validity score less than 3. In Acharya et al the rate of
preterm delivery was observed at 9/79 (11.4%) in the study group and 17/158 (10.8%) in the control group.
In Samson et al the rates of preterm delivery were 44/558 (7.9%) and 14/558 (2.5%) in the study and control
groups respectively. In Nohr et al (2007) the rate of preterm delivery following LEEP was identified at 6.6%,
with an adjusted odds ratio of 1.8 and 95% CI of 1.1-2.9. The preterm delivery rate among the comparison
group was 3.5% with an OR of 1.0. In Michelin et al the rate of preterm delivery was 1/18 (5.5%). The
comparison group was those who were submitted to cold knife conization, in which the preterm delivery rate
was 4/17 (23.5%). In Nohr et al 2009 the preterm delivery rate was 530/8180 (6.5%) with an OR of 2.11 and
95% CI of 1.9-2.3. The rate of preterm delivery after no procedure was 17,106/510,841 (3.3%) with an OR of
1.0. In Jakobsson et al the rate of preterm delivery after LEEP was 75/624 (12%), with an OR of 2.61.
Conclusion: Treatment of cervical intraepithelial neoplasia with the LEEP does appear to be associated with
and increased risk of preterm delivery, ranging from two to three and a half times greater than that of the
general population. Increase in cone height of removed tissue also reflects a greater risk for preterm delivery.
More research needs to be done in order to clarify whether the presence of cervical neoplasia alone is a risk
factor for adverse outcomes on future pregnancy.
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Abstract   
 
Background: Cervical intraepithelial neoplasia (CIN) can be a precursor to the 
development of invasive cervical cancer. There are two ways to approach the treatment of 
CIN, observation or immediate treatment. For women with CIN1, most often observation 
is the best choice. Women diagnosed with CIN2 or CIN3 typically undergo immediate 
treatment, due to the increased likelihood of progression. LEEP is currently the procedure 
of choice, and its association with preterm delivery has been a topic of debate. Many 
studies have been done analyzing the LEEP in an attempt to investigate the association, 
and while this is a promising tool in the treatment of cervical cancer, more research needs 
to be done to reach a definitive conclusion. 
 
Methods: A comprehensive search of the medical literature published within the last five 
years was conducted using MEDLINE, CINAHL, and EBM Multifile. Search terms used 
were: cervical intraepithelial neoplasia, loop electrosurgical excision procedure, and 
pregnancy complications. Web of Science was used in a secondary search to locate 
articles of interest from the references of the included articles. Each article was filtered 
based on strict inclusion and exclusion criteria, and then critically appraised. The validity 
of each article was assessed using the criteria located in Table I. 
 
Results: A total of seven articles were critically appraised. These articles are addressed in 
Table II. After the appraisal, one article was eliminated due to receiving a validity score 
less than 3. In Acharya et al the rate of preterm delivery was observed at 9/79 (11.4%) in 
the study group and 17/158 (10.8%) in the control group. In Samson et al the rates of 
preterm delivery were 44/558 (7.9%) and 14/558 (2.5%) in the study and control groups 
respectively. In Nohr et al (2007) the rate of preterm delivery following LEEP was 
identified at 6.6%, with an adjusted odds ratio of 1.8 and 95% CI of 1.1-2.9. The preterm 
delivery rate among the comparison group was 3.5% with an OR of 1.0. In Michelin et al 
the rate of preterm delivery was 1/18 (5.5%). The comparison group was those who were 
submitted to cold knife conization, in which the preterm delivery rate was 4/17 (23.5%). 
In Nohr et al 2009 the preterm delivery rate was 530/8180 (6.5%) with an OR of 2.11 and 
95% CI of 1.9-2.3. The rate of preterm delivery after no procedure was 17,106/510,841 
(3.3%) with an OR of 1.0. In Jakobsson et al the rate of preterm delivery after LEEP was 
75/624 (12%), with an OR of 2.61.  
 
Conclusion: Treatment of cervical intraepithelial neoplasia with the LEEP does appear to 
be associated with and increased risk of preterm delivery, ranging from two to three and a 
half times greater than that of the general population. Increase in cone height of removed 
tissue also reflects a greater risk for preterm delivery. More research needs to be done in 
order to clarify whether the presence of cervical neoplasia alone is a risk factor for 
adverse outcomes on future pregnancy. 
 
Keywords: Cervical intraepithelial neoplasia, Loop electrosurgical excision procedure, 
Preterm delivery 
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BACKGROUND 
 Cervical intraepithelial neoplasia (CIN) is a precancerous change to the 
epithelium of the cervix. There are three categories of CIN. CIN1 is considered to be low 
grade, and reflects mild dysplastic changes to the lower third of the epithelium. CIN2 
reflects a high grade lesion, and involves dysplasia limited to the basal two thirds of the 
epithelium. CIN3 is also high grade, and is present when dysplasia encompasses from 
greater than two thirds, to the full thickness of the epithelium.1 CIN can be a precursor to 
the development of invasive cervical cancer.   
“The estimated annual incidence in the United States of CIN among women who 
undergo cervical cancer screening is 4 percent for CIN 1 and 5 percent for CIN 2,3.”2 Not 
all CIN lesions will progress to invasive cancer. Low grade lesions (CIN 1) have a 
relatively low likelihood of progression to invasive cancer, while high grade lesions (CIN 
2 and CIN 3) have an increased risk of progression.3 The diagnosis of high-grade CIN 
typically occurs between 25 and 35 years of age, while the diagnosis of cervical cancer is 
often after the age of 40.1 This allows roughly a decade between the time of diagnosis 
with CIN, and the development of cervical cancer.3 Multiple risk factors are associated 
with the development and progression of CIN. 
Some of the common risk factors for the development of CIN include: Human 
papillomavirus (HPV) infection, multiple sexual partners, early coitarche, tobacco 
smoking, and combination oral contraceptives (COC) use, and ethnicity.4-7 Multiple sex 
partners and early coitarche are behavioral factors that are associated with an increased 
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risk of developing HPV infection. In women who smoke tobacco, nicotine and its 
metabolites, are found in the cervical mucus. The presence of the chemicals, especially in 
combination with HPV infection, can advance cellular transformation and neoplasia.3 A 
study of HPV positive women revealed a two to four-fold increase in cervical cancer in 
smokers compared to non-smokers.5 There is evidence supporting the association of an 
increased risk of cervical cancer among women who take COC that directly correlates 
with length of use. Women who have been on COC for 5 or more years have a relative 
risk (RR) of 1.90 compared to non-users.6 The incidence of cervical cancer in the United 
States, is 66 percent higher among Hispanics, and 50 percent higher in African 
Americans as compared to Caucasian women.7 The most notable and influential risk 
factor is considered infection with HPV.  
HPV infection has a strong correlation with the development of cervical 
neoplasia. It is found in 99.7 percent of cervical malignancies.8 Over 100 different strains 
of HPV exist, of which 15 are known to cause cancer.4 Not all women with HPV 
infection develop CIN or cervical cancer. HPV infection is considered to be common, in 
fact, “it is likely that >50% of sexually active adults have been infected with ≥ 1 genital 
HPV type.”9 HPV infection is most often transient, asymptomatic, and self limiting. The 
two most important factors in determining whether the infection will lead to neoplasia are 
HPV subtype and persistence. HPV subtypes 16 and 18 are found in 50 to 60 percent of 
CIN2 and CIN3 cases, and 25 percent of CIN1 cases.10 Persistence of the infection for 
greater than 12 months increases the risk of neoplasia. “In one prospective population 
based cohort study, 21 percent of patients with highly oncogenic HPV infections 
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persisting over 12 months developed CIN 2 or worse over 30 months to follow-up.”11 
Management of CIN depends on the grade of neoplasia and persistence. 
There are two approaches to the management of CIN, observation or immediate 
treatment. For women with CIN1, most often observation is preferred. This involves 
repeat cytology and HPV retesting in 12 months, with referral for colposcopy if the 
woman’s cytology remains HPV positive or shows atypical squamous cells. If CIN1 
persists for longer than 24 months it is acceptable to treat it. Women diagnosed with 
CIN2 or CIN3 typically undergo immediate treatment, due to the increased likelihood of 
progression.12 There are two major treatment modalities, ablation and excision. Ablative 
treatments include cryosurgery, carbon dioxide laser, and electrofulguration. Ablative 
procedures destroy local tissue and do not produce specimens available for further 
evaluation. Due to the nature of the treatment, ablative modalities are suitable for women 
who do not have invasive squamous or glandular disease, and are compliant to follow 
up.12 Excisional modalities include cold knife conization, laser conization, and loop 
electrosurgical excision procedure (LEEP). These procedures allow for a specimen that 
can be examined to ensure negative margins. Excisional treatment is appropriate for 
women who have suspected microinvasion, unsatisfactory colposcopy, or lesions that 
extend into the endocervical canal.12 
Of the excision modalities the LEEP has become the procedure of choice because 
it is cost effective, and can be performed in an outpatient setting.13-15 The LEEP utilizes a 
thin wire loop that is charged with electrical current, allowing for instant coagulation as it 
cuts the tissue. The loop type can be adjusted according to the size and shape of the 
lesion, or loop types of various sizes can be used in sequence.3 The LEEP procedure is 
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considered to be a safe and effective procedure for the treatment of CIN.13,15 
Complications include cramping, bleeding, cervical stenosis, and effects on future 
pregnancy outcome.3 
Purpose of the Study 
 On November 20, 2009 the American College of Obstetrics and Gynecology 
(ACOG), released new guidelines on cervical cancer screening recommendations. These 
guidelines increased the age of initial screening from 18 to 21, and increased the intervals 
between screenings for most women.16 Some of the changes were implemented in an 
attempt to decrease unnecessary exposure to some of the treatment procedures. Most 
women who undergo these procedures are of child bearing age, and some procedures 
have been implicated in causing adverse effects on future pregnancy. LEEP is a 
commonly used outpatient procedure, and its association with adverse pregnancy 
outcomes has been a topic of some debate. 17-22 The primary adverse event documented is 
preterm delivery. Many studies have been done analyzing the LEEP in an attempt to 
investigate the association. Some researchers have reported that the amount of tissue 
removed (cone height) plays an important role,18,19,22,23 while others state the presence of 
cervical neoplasia alone can affect future pregnancy outcome.24,25 LEEP is a promising 
tool in the treatment of cervical cancer; however, more studies need to be done in order to 
reach a definitive conclusion on the efficacy of the procedure. 
 
METHODS 
Search Strategy 
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 A comprehensive search of the medical literature published within the last five 
years was conducted using MEDLINE, CINAHL, and EBM Multifile. Search terms used 
were: cervical intraepithelial neoplasia, loop electrosurgical excision procedure, and 
pregnancy complications. Web of Science was used in a secondary search to locate 
articles of interest from the references of the included articles. 
Inclusion/Exclusion Criteria 
 Articles that were eligible for further analysis were those in which the study 
population included women of reproductive age who underwent LEEP for the treatment 
of CIN, and with the primary outcome of assessing the rate of pre-term delivery. Articles 
were excluded if there was no distinction between LEEP and other conization procedures, 
and if they were not published in the English language. 
 A total of seven articles fulfilled the inclusion and exclusion criteria. Each article 
was critically appraised using standard EBM techniques. Due to the nature of the topic all 
articles were retrospective cohort studies. Therefore, the appraisal included careful 
attention to the methods used in selecting the study population, and ensuring that 
confounding variables were taken in to consideration. The validity of each article was 
assessed using the criteria located in Table I. Each article was given a validity rating with 
four points being the maximum possible score. 
 
RESULTS 
 The search of Medline using the terms cervical intraepithelial neoplasia, loop 
electrosurgical excision procedure, and pregnancy complications yielded 19 results. Of 
the 19 articles 6 met the inclusion and exclusion criteria. The search of CINAHL and 
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EBM Multifile, using the same search terms, yielded 11 and 15 articles respectively. No 
new articles were obtained from these searches. After a comprehensive review of the 
included articles references, one additional article was located using the Web of Science 
database.  
A total of seven articles were critically appraised. These articles are addressed in 
Table II. After the appraisal, one article was eliminated due to receiving a validity score 
less than 3. The results of the remaining six articles were valid. A summary of the 
findings of these articles is displayed in Table III.  
Review Articles 
 The article by Acharya et al17 was a matched retrospective cohort study. The 
study population included women of reproductive age who underwent the LEEP 
procedure between December 1995 and December 2000. The women then must have 
subsequently delivered at the University Hospital of Northern Norway. Women had to be 
under age 45 at the time of the LEEP and only the first pregnancies following the 
procedure were included. Two controls were matched per case by age, parity, previous 
obstetric history, and smoking habit. The primary outcomes of this study were duration of 
pregnancy and birth weight. A total of 79 women were included in the study group, and 
there were 158 matched controls. The rate of preterm pregnancy was observed at 9/79 
(11.4%) in the study group and 17/158 (10.8%) in the control group. The study did not 
show a statistically significant increase in preterm birth after treatment by the LEEP. 
 Samson et al18 performed a retrospective cohort study. The researchers began by 
identifying all women who submitted to the LEEP in Halifax County, Nova Scotia, 
between 1992 and 1999. The study population then included the women who still lived in 
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Halifax County, and delivered at the IWK Health Centre. Only the first pregnancies after 
the procedure were analyzed. The comparison group information was gathered from the 
same database and the controls were matched for age, parity, smoking status, and date of 
delivery. Women were excluded if they had known major risk factors for preterm 
delivery. The primary outcome was rate of preterm delivery. The rates of preterm 
delivery were 44/558 (7.9%) and 14/558 (2.5%) in the study and control groups 
respectively. The odds ratio (OR) was 3.5 with a 95% confidence interval (CI) of 1.9-
6.95. This study concluded that there was a notable increase in the rate of preterm 
delivery after LEEP exposure. Cone height of tissue removed was analyzed as a 
secondary outcome. Samson et al18 concluded “no difference in rate of preterm delivery 
based on characteristics of the LEEP, including depth.” 
 Nohr et al19 (2007) was a population based retrospective cohort study. Women 
included in the study population were those already participating in a Danish population-
based study investigating the natural history of HPV infection. Women in this study were 
between 20-29 years of age. Investigators linked the information of 11 088 women in the 
Danish study with the National Patient Registry, Medical Birth Register, and the 
Pathology Data Bank. They found 14 981 deliveries among 8134 women that were 
eligible for the study. The primary outcomes measured were rate of pre-term delivery and 
cone height. Confounding factors such as maternal age, parity, obstetric history, 
schooling, smoking during pregnancy, and date of delivery were adjusted for. Of the 14 
981 deliveries 541 were preterm. The rate of preterm delivery following LEEP was 
identified at 6.6%, with an adjusted odds ratio of 1.8 and 95% CI of 1.1-2.9. The preterm 
delivery rate among the comparison group was 3.5% with an OR of 1.0. This suggests 
15 
 
almost a two-fold increase in pre-term delivery among the women treated with LEEP. 
Women who underwent LEEP with a cone height of 14-16mm had a 7.4% rate of preterm 
delivery (compared to 3.5% in the control group), with an OR of 2.1. If the cone height 
was equal to or greater than 17mm the preterm delivery rate was 20%, with an OR of 5.6. 
This implies an increased risk in preterm delivery that correlates with an increase in cone 
height.  
 Michelin et al20 conducted a retrospective study. The study group was collected 
by analyzing the surgical specimens of women who submitted to LEEP or cold knife 
conization from January 1991 to December 2004 at the Research Institute of Oncology – 
IPON/UFTM in Brazil. The included patients were women 18 to 45 years of age. The 
primary outcomes were preterm birth, low birth weight, and miscarriage. Of the 199 
patients who met the inclusion criteria, 95 were LEEP cases. Of the 95, 18 women went 
on to deliver. The rate of preterm delivery was 1/18 (5.5%). The comparison group was 
those who were submitted to cold knife conization, in which the preterm delivery rate 
was 4/17 (23.5%). This article concluded that preterm delivery was much greater among 
cold knife conization. 
 Nohr et al21 (2009) completed a retrospective population-based study. All 
deliveries in Denmark between 1997 and 2005 were considered. Data was gathered using 
the National Patient Registry, Medical Birth Register, and the Danish Registry of 
Pathology databases. A total of 552 678 deliveries were eligible for statistical analysis. 
Confounding factors including year of delivery, maternal age, smoking during pregnancy, 
and marital status during pregnancy were adjusted for. The primary outcome of interest 
was preterm delivery. Of the eligible deliveries 8180 were after LEEP. The preterm 
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delivery rate was 530/8180 (6.5%) with an OR of 2.11 and 95% CI of 1.9-2.3. The rate of 
preterm delivery after no procedure was 17,106/510,841 (3.3%) with an OR of 1.0. This 
reflects a two fold increase in preterm delivery after LEEP. 
 Jakobsson et al22 performed a retrospective cohort study. The study population 
included 672 women having outpatient treatment for CIN from 1997-2003 and 
subsequent delivery at the Department of Obstetrics and Gynaecology, Helsinki 
University Hospital and at the Maternity Hospital, Helsinki, Finland until 2006. The 
primary outcome assessed was rate of pre-term delivery. Age and parity were adjusted 
for. The rate of preterm delivery after LEEP was 75/624 (12%), with an OR of 2.61. This 
rate was compared to a calculated pre-term delivery rate of 4.6%. This study concluded a 
nearly three-fold increase in pre-term delivery. 
DISCUSSION 
Preterm Delivery 
 Of the six articles reviewed, five concluded that there was an increase in preterm 
delivery among women treated with the LEEP.18-22 There were four articles that received 
the maximum possible validity score: Acharya et al17, Samson et al18, Nohr et al19 (2007), 
and Nohr et al21 (2009). The increase in preterm delivery cited in these studies ranged 
from no statistically significant increase to an over three fold increase. The studies by 
Acharya et al and Samson et al were performed in a very similar manner. Both matched 
cases and controls before analysis, controlled for the same variables, and analyzed only 
the first pregnancies after the procedure. The results however, were strikingly different, 
with Acharya et al concluding no statistically significant increase and Samson et al 
concluding that there was an over three fold increase in preterm delivery. The methods in 
17 
 
both of the Nohr et al papers were also quite similar. Unlike Samson et al and Acharya et 
al, the study population was composed of a cohort of deliveries, not a cohort of women. 
In both studies multiple deliveries per woman were considered, and they included the 
deliveries in those who underwent more than one procedure. These methods are still 
valid, but limited. Both concluded roughly a two-fold increase in preterm delivery. Based 
on the results of a majority of the studies, the LEEP does appear to be associated with an 
increase in preterm delivery. The exact rate of this increase is still unclear, and will 
continue to be a topic of discussion. 
Cone Height 
 An issue of debate concerning the LEEP is whether or not the height of the cone 
of removed tissue is associated with the rate of preterm delivery. Many of the reviewed 
studies were analyzing this as a secondary outcome.18,19,22 Samson et al18 concluded that 
the cone height did not have an effect on the rate of preterm delivery, while Nohr et al19 
concluded that the cone height significantly increased the rate of preterm delivery. 
However, both of these studies were limited by the amount of data available in the 
pathology reports. There is no standard in place regarding how to report specimen 
dimensions, therefore, data was missing in some cases. In a study published by Nohr et al 
in December 2009,23 researchers consulted with pathologists to compose standardized 
guidelines for registration of the specimens. With these standards in place they were able 
to analyze accurate data. They concluded there was a “significant increase in preterm 
delivery with increasing cone depth, with an estimated 6% increase in risk per each 
additional millimeter of tissue excised (OR 1.06, 95% CI 1.03-1.09).” This is an 
extremely important and surprising development. Providers who perform the LEEP 
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should be informed of these recent findings and take precautions, to remove the minimum 
amount necessary to ensure negative margins. Standards on information gathering will 
need to be a major focus in future studies. 
Risks of Cervical Intraepithelial Neoplasia 
 Some studies have suggested that the presence of CIN alone is a risk factor for 
adverse outcomes in pregnancy, including preterm birth, regardless of the treatment 
modality.24,25 A study conducted by Bruinsma et al24 published in 2006, reported that 
women who were diagnosed with precancerous changes to the cervix, and not treated, 
were at an increased risk of preterm delivery as compared to the general population 
(standardized prevalence ratio (SPR) 1.5, 95% CI 1.4-1.7). A second study by Shanbhag 
et al25 published in October 2009, compared excisional treatments to no treatment. The 
excisional group had a preterm delivery rate of 12%, while the no treatment group 
showed a 15% preterm delivery rate, however, these values were not proven to be 
statistically significant. This study did show a separate and interesting finding that was 
statistically significant. They found that the risk of perinatal mortality in the untreated 
group was seven and a half times that of the excisional group (the 95% CI was wide, but 
the p-value was .005). This statistic is quite shocking, and illustrates that the risks 
associated with the procedure may be far less than the risks associated with no treatment. 
The findings in both studies suggest that the presence of CIN may be an independent risk 
factor for preterm delivery, however, more research needs to be done on this topic to 
reach a definitive conclusion.  
Study Limitations 
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 Due to the nature of the topic the ideal randomized controlled trial will never be 
done to assess the effects of the LEEP on pregnancy outcomes. It would be unethical to 
assign women to a no treatment group with the presence of precancerous cervical 
changes. Most of the available literature on this topic is thus retrospective, and carries 
with it the inherent limitation of retrospectively analyzed data. The research is limited to 
the available data, and often, records are missing information. There are numerous cases 
in which there is no standard in place for how to chart patient information, as it is unclear 
what may become important to researchers at some later date, they are often left to 
interpret weak or unclear information. Retrospective cohort studies also leave the door 
open for introduction of bias when selecting study populations. To address these issues, 
the ideal solution would be to conduct a prospective observational study. This would 
allow standards to be developed for gathering and recording information before the study 
begins, and to fix criteria on the selection of the population to be studied, in order to 
decrease bias.  
 All of the studies were able to control for confounding variables. In Acharya et 
al17 and Samson et al18 confounding variables were controlled for when selecting the 
study groups. The others adjusted the results for confounding variables. It would have 
been ideal if all studies controlled for the confounding variables in a similar fashion.  
 Study populations were different among the articles. Nohr et al19,21 considered the 
data on actual deliveries. With the research performed in this manner, it allowed for 
multiple deliveries per woman to be considered, and did not focus on the woman’s 
outcome after the procedure. In Acharya et al17 and Samson et al18 the study analyzed 
only the first pregnancies of specific women following the procedure. Conducting the 
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study in this manner is more appropriate to clinical practice, as it is the patient that should 
be the focus rather than data on anonymous deliveries. 
 
CONCLUSION 
Treatment of cervical intraepithelial neoplasia with the LEEP does appear to be 
associated with an increased risk of preterm delivery. Of the studies reviewed, five out of 
six reported that there was an increased risk for pre-term delivery after the LEEP.18-22 The 
increase in risk was anywhere from two to three and a half times greater than that of the 
general population. Cone height of the tissue removed also proved to be an important 
factor. The more cervical stroma disrupted, the greater the risk for preterm delivery. 
Further research needs to be done to clarify whether the presence of cervical neoplasia 
alone is a risk factor for adverse outcomes in future pregnancy. LEEP is still a safe and 
effective procedure for the treatment of CIN, but providers should educate their patients 
on the available treatment options and the risks associated with each.  
 The LEEP has been used in the treatment of CIN for over a decade. As the years 
have passed, research has been uncovering the risks and side effects associated with the 
procedure. In order to accurately calculate these risks, there needs to be a focus on 
meticulous record keeping. Factors such as loop size, number of passes, and the length, 
width, and weight of tissue excised, need to be charted accurately. Maternal 
characteristics before and after delivery, as well as, perinatal outcomes must be reported 
correctly. This concept is essential in paving the way for future research. 
 New cervical cancer screening guidelines were established by the ACOG in 
November 2009. They suggested an increase in the age of the patient at initial screening 
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and lengthened the time between screenings for most women. The fear was, that too 
many women of childbearing age were being exposed to procedures such as the LEEP, 
which may be associated with adverse outcomes in future pregnancy. Due to the nature of 
CIN and its slow progression to cervical cancer, these new guidelines are appropriate. 
They will decrease the exposure to procedures such as the LEEP. As long as women 
adhere to the guidelines and undergo the recommended screenings, even with the 
increased intervals, the CIN will be diagnosed with adequate time to treat before it 
progresses to cervical cancer. Providers should reassure any patients with concerns about 
the safety of the new guidelines. 
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TABLES 
 
Table I. Validity Criteria 
 
Criteria Variables 
Power >75 cases 
Quality of Methods 
Study and control groups treated similar, 
All cases accounted for, Clearly 
reproducible methods 
Confounding Variables 
Acknowledgement of confounders, 
Adjustment for confounders, 
Explanation for non-adjustment 
Quality of Results Reported correctly, Accuracy, Clear explanation without hidden information 
One point assigned per criteria, 4 points maximum possible score 
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Table II. Matrix of Reviewed Literature 
 
Study/ Design Population Comparison Primary Outcomes Validity/Comments 
Acharya et al 
(2005)17  
Matched 
Cohort 
79 Women 
158 Controls 
LEEP vs No 
LEEP 
Duration of 
pregnancy, 
Birth weight 
4/4 
Samson et al 
(2005)18  
Matched 
Cohort 
571 Women 
571 Controls 
LEEP vs No 
LEEP 
Pre-term 
delivery 
4/4 
 
Nohr et al 
(2007)19 
Retrospective 
Cohort 
349 Deliveries 
14,567 
Controls 
LEEP vs No 
LEEP 
Pre-term 
delivery, Cone 
height 
4/4  Considers 
multiple deliveries 
per woman 
Michelin et al 
(2008)20 
Retrospective 
Cohort 
18 Women 
17 Controls 
LEEP vs Cold 
knife  
Pre-term 
delivery, Birth 
weight, 
Miscarriage 
3/4  Small power, 
Compares  against 
cold knife 
Patrelli et al 
(2008)26  
Retrospective 
Cohort 
45 Women 
General 
population 
LEEP or Cold 
knife vs 
General 
Population 
Duration of 
pregnancy, 
Pregnancy 
outcomes, 
Mode of 
delivery, 
Excision parity 
2/4 Small power,  
Discrepancy in 
reporting results 
Nohr et al 
(2009)21 
Retrospective 
Cohort 
Population 
based 
8180 
Deliveries 
510,814 
Controls 
LEEP vs No 
Leep 
Pre-term 
Delivery 
4/4  Considers 
multiple deliveries 
per woman 
Jakobsson et al 
(2009)22 
Retrospective 
Cohort 
624 Women 
General 
population 
LEEP vs 
General 
population 
Pre-term 
delivery 
3/4  No control 
group 
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Table III. Summary of Findings 
 
Study Acharya et al (2005)17  
Samson et 
al (2005)18  
Nohr et al 
(2007)19  
Michelin et 
al (2008)20 
Nohr et al 
(2009)21  
Jakobsson 
et al 
(2009)22 
Procedure LEEP None LEEP None LEEP None LEEP None LEEP None LEEP None 
Number 79 158 558 558 95 14,564 18  8180 510,841 624  
# Preterm 9 17 44 14   1  530 17,106 75  
% 
Preterm 11.4 10.8 7.9 2.5 6.6 3.5 5.5  6.5 3.3 12 4.6* 
OR   
3.5 
(1.9-
6.95) 
 
1.8 
(1.1-
2.9) 
1.0   
2.11 
(1.9-
2.3) 
1.0 2.61  
* Singleton preterm pregnancy rates from 97”- 06”, calculated from Medical Birth 
Register, Finland.  
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